Metastasizing tumor cells must transmigrate the dense extra-cellular matrix (ECM) that surrounds most organs. The use of 3-dimensional (3D) collagen gels has revealed that many cancer cells can switch between different modes of invasion that are characterized by distinct morphologies (e.g., rounded vs. elongated). The adhesion protein NEDD9 has the potential to regulate the switch between elongated and rounded morphologies; therefore, its role was interrogated in the invasion switch of glioblastoma and neuroblastoma tumors that similarly derive from populations of neural crest cells. Interestingly, siRNA-mediated depletion of NEDD9 failed to induce cell rounding in glioma or neuroblastoma cells, contrasting the effects that have been described in other tumor model systems. Given that Rac1 GTPase has been suggested to mediate the switch between elongated and rounded invasion, the functionality of the Rac1 morphology switch was evaluated in the glioma and neuroblastoma cells.
Introduction
The adhesion docking protein NEDD9/HEF1/Cas-L is a member of the Cas family of proteins that includes p130Cas/Bcar1, Efs/Sin and HEPL/CASS4. 1 Increasing studies point to a critical role for NEDD9 as a regulator of migration and invasion in diverse cancer types. 2 In addition to this pathological role, NEDD9 was first identified in a screen for neural precursor cell and developmentally down-regulated genes 3 and was subsequently shown to regulate migration in neural pre-cursor/neural crest cells. 4 The neural crest cells are a highly migratory cell type that give rise to a variety of cell lineages that includes peripheral neurons, glia and melanocytes. 5 In turn, transformation of neural crest cell populations is thought to give rise to neuroblastoma, glioma brain tumours and melanoma. Progression to invasive disease remains a significant impediment to successful treatment for each of these tumour types. The neuroblastomas are the most common extra-cranial tumour of childhood and the majority of patients present with metastatic disease. In contrast to other tumour types, gliomas rarely metastasize to secondary sites but instead the high grade gliomas (grade III and IV) extensively infiltrate the surrounding health brain tissue.
Based on recent insights into the role of NEDD9 in the invasive behaviour of melanoma 6, 7 we have investigated the role of NEDD9 in glioma and neuroblastoma invasion that exhibits the features of invading neural crest cells.
NEDD9 is expressed during embryonic brain development but is down-regulated in the normal adult brain 3 upon lineage commitment of progenitor cells. 8 NEDD9 is specifically expressed in nestin-positive neural crest cells that emigrate from the dorsal tube. 4 The characteristic invasive morphology of the neural crest cells is suggested to closely resemble that of invasive glioma cells. 9, 10 Uniquely among the Cas family proteins, NEDD9 was required for the invasion of U87MG glioblastoma cells through brain homogenates. 11 NEDD9 is elevated in high grade glioma cells and high level expression in low grade glioma correlated with significantly poorer prognosis and increased invasion. 12 In contrast, the morphological regulation of invasive neuroblastoma is comparatively less well defined. Notably, NEDD9 was defined as an all trans-retinoic acid responsive gene upregulated in response to retinoic acid induced neuritogenesis in neuroblastoma cells. 13 3D collagen gels that mimic the in vivo interstitial environment have been key in demonstrating the plasticity of cancer cell invasion mechanisms. 7, 14, 15 15 Similarly, simultaneous Rac1 and Rac3 depletion, together with Rho kinase inhibition, was required in order to comprehensively arrest 3D collagen invasion by highly invasive cells isolated from the peri-tumoral region of a high grade glioma. 18 While there appears to be no reports to date having examined whether neuroblastoma cells undergo morphological transition in 3D collagen culture following Rac inhibition, in 2D conditions Rac1 and Rac3 isoforms have apparently opposite effects on cellular morphologies. 19 These studies therefore suggest that Rac
GTPase may be a critical determinant of high grade glioma and neuroblastoma 3D
morphologies.
In the present study we have investigated the role of NEDD9 in regulating 3D
invasive morphologies of high grade glioma and neuroblastoma cells. Using publicly available expression data we show a significant association between NEDD9 expression and poor survival rates for both tumour types. Importantly, in contrast to effects seen in melanoma, NEDD9 depletion fails to induce a morphological switch in either high grade glioma or neuroblastoma cells. Notably, while the neuroblastoma cells exhibit a robust morphological switch in response to Rac inhibition, this affect is much reduced in the high grade glioma cells. Instead, we find that NEDD9 depletion significantly reduces migration speed of cells as they negotiate the 3D collagen environment. Collectively, our data reveal that NEDD9 plays a significant role in regulating cell speed in 3D environments, independently of the Rac-mediated morphological switch. Growth of cells in 3D collagen gels, media for live imaging and invasion assays through 3D collagen gels was based on protocols previously reported to identify invasion plasticity 20 and as we have previously employed 21 . Post image capture, nuclear translocation was tracked in time-lapse stacks using Metamorph V6.3 software (Molecular Devices). Calculation of Mean Squared Displacement (MSD) was performed as previously described. 24 We note that only 
RESULTS

NEDD9 expression in glioma and neuroblastoma
We first examined the relationship between NEDD9 expression and patient survival in both glioma and neuroblastoma. This was achieved using publicly available data from the REpository for Molecular BRAin Neoplasia DaTa (REMBRANDT) homepage (http://rembrandt.nci.nih.gov) and the Oncogenomics website 
NEDD9 depletion does not induce rounding
It has previously been established that NEDD9 regulates the morphological switch from elongated to rounded 3D invasion in melanoma cells. 7 Thus we questioned the effect of NEDD9 depletion on glioblastoma cell morphology, focusing on the A172
and DBTRG cells due to their high endogenous levels of NEDD9 expression. Under We next questioned the effect of NEDD9 depletion on neuroblastoma cell morphology, using the SH-EP line that has high endogenous NEDD9 expression ( Figure 1C ). In 3D collagen gels, the SH-EP cells have a mixed morphology with ~ 50% of cells exhibiting an elongated phenotype ( Figure 2D and 2F). NEDD9 depletion was achieved using two independent siRNA sequences (siRNAa and siRNAb) ( Figure 2E ). Again, visual inspection of the cultures suggested little effect on cell rounding ( Figure 2D ). Quantification revealed that NEDD9 depletion with siRNAa caused a small decrease in the percentage of round cells, while siRNAb caused a small increase in cell rounding ( Figure 2F ). However this only represented a change from an average of 53% rounded under control conditions, to 50% and 57%, respectively. Thus, in contrast to effects on melanoma cells 7 
present data suggest that NEDD9 depletion has a minimal effect on the morphology of either glioblastoma or neuroblastoma cells.
Differential response to Rac1 inhibition
We considered that the lack of effect of NEDD9 depletion on the cell morphologies may reflect absence of the morphological switch (elongated/mesenchymal to rounded/amoeboid) in these cells. Rac GTPase is a major regulator of the switch between elongated and rounded invasion 7, 15 and NEDD9 is an upstream regulator of this pathway in melanoma cells. 
compensate. Rac 3 is highly expressed in the brain 27 and both Rac1 and Rac3 are suggested to play a key role in glioblastoma invasion. 28 Thus we questioned whether A172 rounding may require the inhibition of both Rac1 and Rac3 isoforms. Depletion was achieved using siRNA-specific for each Rac isoform as previously described. 15 Due to the absence of commercially-available isoform specific antibodies, confirmation of knock-down was determined by comparing the levels of total Rac protein ( Figure 4A) . Notably, only siRNA targeting Rac1, not Rac3, significantly decreased levels of total Rac protein ( Figure 4B ). Since it has previously been suggested that Rac3 depletion may lead to a corresponding increase in Rac1 protein 15 ,
we proceeded with the double knock-down of Rac1 and Rac3 and examined the morphology of cells resulting from all three siRNA conditions. This analysis revealed that combined depletion of Rac1 and Rac3 had no effect on cellular morphologies in 3D collagen gels ( Figure 4C and 4D) . Similarly, individual targeting of the Rac isoforms had no effect on A172 morphology. It is interesting that Rac knock-down was not able to recapitulate the small increase in rounding that was seen in cells expressing dominant negative Rac (Figure 3) , despite a significant reduction in total Rac protein levels ( Figure 4A ). Together, these data emphasize that the A172 cells have a limited response to the Rac-dependent morphology switch.
Given that the Rac morphology switch appears to be robustly functioning in the SH-EP cells, we next questioned the isform-specific role of Rac in SH-EP 3D morphology. While Rac1 depletion significantly reduced total Rac protein levels, Rac3 depletion had no effect ( Figure 5A and 5B) either that Rac3 may not be Figure 6D) . Notably, following NEDD9 knock-down the cells continued to display rounded cell bodies with a leading membrane protrusion, with occasional pausing as the cells retracted the protrusion and adopted a rounded shape, but had slower progress through the gel ( Figure 6E ). Together these data reveal that NEDD9 depletion reduces 3D migration speed, without stimulating transition to rounded invasion.
Discussion
Based on insights from developmental biology, in the present study we have investigated the role for NEDD9 in the migration of tumours that derive from neural crest cell populations. We employed 3D collagen gel models to investigate invasion plasticity in response to altered NEDD9 expression. 7, 20 Importantly, while we show cell-type differences in regard to invasion plasticity control by Rac GTPase activity, the cell lines investigated in the present study are united by their lack of morphological switch following NEDD9 depletion. Thus our data suggest that NEDD9 may not universally regulate the transition between morphologically distinct invasion phenotypes. Instead, we find that NEDD9 is an important determinant of the speed with which cells negotiate the 3D extracellular environment.
Prior to initiating investigations of NEDD9 and migration in glioma and neuroblastoma cell lines, we first determined whether there is any clinical association between NEDD9 and survival in these tumour types. Related to this, a recent study showed that higher level NEDD9 in lower grade glioma tumours is associated with reduced progression free survival. 12 In proliferative and mesenchymal, with corresponding increase in aggressiveness. 29 Potentially, NEDD9 expression may prove to be more prominent in one of these subclasses, particularly given recent reports suggesting a correlation between NEDD9 and nestin expression in glioma. 12 We observed a striking inverse relationship between NEDD9 expression and patient survival in the sub-set of neuroblastomas that lack N-myc amplification. Critically, ~65% of patients with metastatic disease have no N-myc amplication and variable clinical behaviours of these tumours complicate treatment decisions thus there is an important need for molecular markers that can stratify these tumours. 30 Together, these analyses expand the range of tumour types in which high level NEDD9 expression has been correlated with reduced patient survival rates including melanoma 6 , lung adenocarcinoma [31] [32] [33] and head and neck cancer. 
that there may be cell-type specific differences in the effects of NEDD9 on invasion plasticity. Importantly, we confirmed that the SH-EP cells exhibit a robust switch to rounded morphology following Rac1 depletion. Thus these cells are clearly competent to undergo morphological transition. By contrast, the A172 glioblastoma cells exhibited limited morphological transition following Rac inhibition. The small morphological change in A172 seen following dominant negative Rac inhibition is likely due to the well-described non-specific inhibition of other Rho family GTPases following high level expression of this construct 35 .
In contrast to our data, other high grade glioma cell lines such as the U87MG cells undergo morphological transition to rounded invasion following Rac inhibition. Rho kinase inhibition and cannot be blocked by Rac inhibition. 23 Thus, at least in these two examples it appears that NEDD9 may not be regulating cellular morphologies via activation of Rac1 GTPase.
The striking finding from our study is that in each case NEDD9 depletion significantly reduced the speed of 3D cell migration. Importantly, this suggests a similar mechanism of NEDD9 action in these tumour types from diverse backgrounds. The 3D collagen matrix requires cells to either deform themselves in order to squeeze through pores in the matrix (rounded invasion) or alternatively deform the matrix via exerting force through adhesion to the matrix and secreting enzymes to degrade the matrix (elongated invasion). 36 Significantly, NEDD9 depletion reduced speed, without altering elongated morphologies. Similarly, let-7i
microRNA-mediated inhibition of the Twist/NEDD9/Rac1 signalling pathway in head and neck cancer cells reduced the speed of elongated cell migration. 34 We have previously shown that mouse embryo fibroblasts lacking NEDD9 expression exhibited reduced adhesive force to the extra-cellular matrix. 16 Thus it is possible that the reduced migration speed exhibited following NEDD9 depletion may be due to decreased adhesive force to the surrounding matrix. Alternatively, given that NEDD9 has previously been shown to modulate matrix metalloproteinase expression 37 
